The key enzyme in this pathway, Serine Hydroxymethyltransferase (SHMT), has been found to be upregulated in BLCA, promoting tumor cell proliferation and inhibiting apoptosis12. This evidence concerns the gene SHMT2 and bladder transitional cell carcinoma.